feed,title,long_url,short_url
Benzinga,Organon Inks Licensing Pact For Dar√© Bioscience's Bacterial Vaginosis Treatment,https://benzinga.com/general/biotech/22/03/26397795/organon-inks-licensing-pact-for-dar-biosciences-bacterial-vaginosis-treatment,https://bit.ly/3NEM6k0
Benzinga,"Eloxx to Test Its Lead Product Candidate, ELX-02, In Rare Kidney Disease",https://benzinga.com/general/biotech/22/03/26398610/eloxx-to-test-its-lead-product-candidate-elx-02-in-rare-kidney-disease,https://bit.ly/35qlFx0
Benzinga,Vertex Touts Positive Data From Mid-Stage Study Of Its Non-Opioid Pain Drug,https://benzinga.com/general/biotech/22/03/26401067/vertex-touts-positive-data-from-mid-stage-study-of-its-non-opioid-pain-drug,https://bit.ly/3qQpQtw
